|
Symbol
|
RMBFCV | ACUCTQ | ACZZSQ | AETSTQ | RKPRCH | RMAUVV | AGZWTQ | DXDBKB | AHCQTQ | SLWRCH | DYABKB | DYMBKB | RMBMNV |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Nom | Auto-Callable Multi Defender VONTI | Callable Multi Barrier Reverse Convertible | Barrier Reverse Convertible | Multi Barrier Reverse Convertible | Worst of Reverse Convertible | Callable Multi Defender Vonti | Callable Multi Barrier Reverse Convertible | Barrier Reverse Convertible | Barrier Reverse Convertible | Barrier Reverse Convertible | Barrier Reverse Convertible | Barrier Reverse Convertible | Callable Multi Defender Vonti |
|
Sous-jacent
|
AMS AG / Zur Rose Group AG | DOCMORRIS AG / Novartis AG / Sandoz Group AG | Shop Apotheke Europe / Zur Rose Group AG | DOCMORRIS AG / Stadler Rail AG | Bachem Hldg. AG / DOCMORRIS AG | DOCMORRIS AG / Sandoz Group AG | AMS AG / Idorsia AG / Zur Rose Group AG | DOCMORRIS AG / Idorsia AG / Novartis AG | AMS AG / Idorsia AG / Zur Rose Group AG | Idorsia AG / Zur Rose Group AG | AMS AG / Idorsia AG / Zur Rose Group AG | AMS AG / Zur Rose Group AG | Bachem Hldg. AG / DOCMORRIS AG / Sandoz Group AG / Ypsomed Hldg. AG |
|
Emetteur
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Échéance
|
12.07.2027 | 29.10.2026 | 22.12.2026 | 13.11.2026 | 15.12.2026 | 14.05.2027 | 14.10.2027 | 03.11.2027 | 03.11.2027 | 10.08.2027 | 17.11.2027 | 24.11.2027 | 30.08.2027 |
| Demande | 46,400 | - | 85,40 | 117,63 | 103,93 | 103,10 | 99,75 | 97,81 | 99,54 | 98,86 | 97,71 | 97,24 | 99,10 |
| Offre | - | - | - | 118,57 | 104,76 | 104,50 | 100,55 | 98,61 | 100,34 | 99,66 | 98,51 | 98,04 | 100,30 |